MENU
SPRO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Spero Therapeutics (SPRO) Earnings Date & Reports
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm... Show more
Industry: #Pharmaceuticals Major
A.I. Advisor
published Earnings
SPRO is expected to report earnings to -15 cents per share on November 16
Q3'26
Est.
$-0.16
Q2'26
Beat
by $0.01
Q1'26
Beat
by $0.05
Q4'25
Beat
by $0.73
Q3'25
Beat
by $0.26
The last earnings report on August 12 showed earnings per share of -15 cents, beating the estimate of -17 cents. With 310.71K shares outstanding, the current market capitalization sits at 70.46M.
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information
General Information
a developer of novel therapies for the treatment of resistant bacterial infections
Industry Biotechnology
Profile
Details
Industry
Pharmaceuticals Major
Address
675 Massachusetts Avenue
Phone
+1 857 242-1600
Employees
25
Web
https://www.sperotherapeutics.com